HC Wainwright maintains Verastem price target at $18
HC Wainwright & Co. maintained its $18.00 per-share price target on Verastem, according to Benzinga’s ratings-action roundup.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.